Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

December 31, 2021

Conditions
COVID
Interventions
DEVICE

2019-nCoV IgG/IgM Rapid Test Cassette

The specimen (whole blood, serum, plasma) will be loaded into the cassette and will migrate via capillary action along the membrane to react with the gold conjugate. The result will be available in 10 minutes

Trial Locations (5)

20133

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milan

20141

European IO, Division of Early Drug Development for Innovative Therapies, Milan

20162

Azienda Ospedaliera Niguarda Cà Granda, Milan

24127

Papa Giovanni XXIII Hospital, Bergamo

Unknown

Azienda Socio-Sanitaria Territoriale di Cremona, Cremona

All Listed Sponsors
collaborator

Azienda Socio Sanitaria Territoriale di Cremona

OTHER

collaborator

Azienda Ospedaliera Niguarda Cà Granda

OTHER

collaborator

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

OTHER

collaborator

Papa Giovanni XXIII Hospital

OTHER

lead

European Institute of Oncology

OTHER

NCT04434417 - Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV | Biotech Hunter | Biotech Hunter